Matthews Judith M. 4
4 · Iterum Therapeutics plc · Filed Jun 25, 2021
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-23+1,936,000→ 1,936,000 totalExercise: $2.01Exp: 2031-06-22→ Ordinary Shares (1,936,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 23, 2021 and the remaining 75% will vest in equal monthly installments thereafter until June 23, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.